Inactivation of yellow fever virus by WHO-recommended hand rub formulations and surface disinfectants.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 13 11 2023
accepted: 01 06 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

Despite continued outbreaks of yellow fever virus (YFV) in endemic regions, data on its environmental stability or guidelines for its effective inactivation is limited. Here, we evaluated the susceptibility of the YFV 17D vaccine strain to inactivation by ethanol, 2-propanal, World Health Organization (WHO)-recommended hand rub formulations I and II, as well as surface disinfectants. In addition, two pathogenic strains were tested to compare inactivation kinetics by WHO-recommended hand rub formulations I and II. Furthermore, environmental stability of the vaccine strain was assessed. YFV 17D particles displayed infectivity half-life decay profiles of ~13 days at room temperature. Despite this extended environmental stability, YFV was efficiently inactivated by alcohols, WHO-recommended hand formulations, and four out of five tested surface disinfectants. These results are useful in defining disinfection protocols to prevent non-vector borne YFV transmission.

Identifiants

pubmed: 38900788
doi: 10.1371/journal.pntd.0012264
pii: PNTD-D-23-01429
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0012264

Informations de copyright

Copyright: © 2024 Meister et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Toni Luise Meister (TL)

Department for Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
Institute for Infection Research and Vaccine Development (IIRVD), Centre for Internal Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Germany.
German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Nicola Frericks (N)

Department for Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.

Robin D V Kleinert (RDV)

Division of Veterinary Medicine, Paul-Ehrlich-Institute, Langen, Germany.

Estefanía Rodríguez (E)

German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Joerg Steinmann (J)

Institute of Clinical Hygiene, Medical Microbiology and Infectiology, General Hospital Nürnberg, Paracelsus Medical University, Nuremberg, Germany.
Institute of Medical Microbiology, University Hospital of Essen, Essen, Germany.

Daniel Todt (D)

Department for Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
European Virus Bioinformatics Center (EVBC), Jena, Germany.

Richard J P Brown (RJP)

Department for Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
Division of Veterinary Medicine, Paul-Ehrlich-Institute, Langen, Germany.

Eike Steinmann (E)

Department for Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
German Centre for Infection Research (DZIF), External Partner Site, Bochum, Germany.

Classifications MeSH